Fed. Circ. Affirms Invalidity Of J&J Stent Patents
The Federal Circuit on Tuesday upheld a determination that four Johnson & Johnson patents for drug-eluting stents were invalid for lack of adequate written description, handing a victory to Boston Scientific...To view the full article, register now.
Already a subscriber? Click here to view full article